Shareholding2 Sept 2026, 10:48 am
Parmax Pharma: Dhiren Shah & PACs Disclose Shareholding Changes
AI Summary
Parmax Pharma Ltd has filed a disclosure under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, detailing changes in shareholding by Dhiren Shah and Persons Acting in Concert (PACs). The acquirers and PACs, considered part of the promoter group, have acquired 22,80,444 equity shares and 17,16,574 warrants pursuant to a preferential issue. This acquisition, approved by BSE, has altered their total holding. The filing provides a detailed breakdown of share and warrant acquisition before and after the transaction, impacting their overall stake in the company.
Key Highlights
- Dhiren Shah & PACs disclosed shareholding changes under SEBI Takeover Regulations.
- Acquirers and PACs are part of the promoter group.
- Acquisition includes 22,80,444 equity shares and 17,16,574 warrants.
- The preferential issue was approved by BSE and allotted on August 29, 2026.
- Post-acquisition, the promoter group's total holding stands at 68.34%.
Price Impact
More from PARMAX